The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Systematic review and meta-analysis
(2019) · Providing Information for Health · doi:10.1201/9781315377315-19 · Cited by 2,659
Platelet Activation and Atherothrombosis
Davì, G., & Patrono, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071014 · Cited by 2,135
Self-citationA Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women
Ridker, P. M., Cook, N. R., Lee, I.-M., Gordon, D., Gaziano, J. M., Manson, J. E., Hennekens, C. H., & Buring, J. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050613 · Cited by 1,945
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., Vyas, S. N., & FitzGerald, G. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003199 · Cited by 1,394
Low-Dose Aspirin for the Prevention of Atherothrombosis
Patrono, C., García Rodríguez, L. A., Landolfi, R., & Baigent, C. (2005) · New England Journal of Medicine · doi:10.1056/nejmra052717 · Cited by 1,218
Self-citationThe way I see it: House officers need formal career development
Connor, A. (2002) · BMJ · doi:10.1136/bmj.324.7336.s71 · Cited by 1,143
Gum, P. A., Kottke-Marchant, K., Welsh, P. A., White, J., & Topol, E. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)03014-0 · Cited by 1,022
Patrignani, P., Filabozzi, P., & Patrono, C. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110576 · Cited by 937
Self-citationAspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysis
Krasopoulos, G., Brister, S. J., Beattie, W. S., & Buchanan, M. R. (2008) · BMJ · doi:10.1136/bmj.39430.529549.be · Cited by 708
FitzGerald, G. A., Oates, J. A., Hawiger, J., Maas, R. L., Roberts, L. J., Lawson, J. A., & Brash, A. R. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110814 · Cited by 665
Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects
Patrono, C., Ciabattoni, G., Pinca, E., Pugliese, F., Castrucci, G., De Salvo, A., Satta, M. A., & Peskar, B. A. (1980) · Thrombosis Research · doi:10.1016/0049-3848(80)90066-3 · Cited by 651
Self-citationInhibition of platelet prostaglandin synthetase by oral aspirin.
Burch, J. W., Stanford, N., & Majerus, P. W. (1978) · Journal of Clinical Investigation · doi:10.1172/jci108941 · Cited by 558
Clinical pharmacology of platelet cyclooxygenase inhibition.
Patrono, C., Ciabattoni, G., Patrignani, P., Pugliese, F., Filabozzi, P., Catella, F., Davì, G., & Forni, L. (1985) · Circulation · doi:10.1161/01.cir.72.6.1177 · Cited by 454
Self-citationReilly, I., & FitzGerald, G. (1987) · Blood · doi:10.1182/blood.v69.1.180.180 · Cited by 419
Gurbel, P. A., Bliden, K. P., DiChiara, J., Newcomer, J., Weng, W., Neerchal, N. K., Gesheff, T., Chaganti, S. K., Etherington, A., & Tantry, U. S. (2007) · Circulation · doi:10.1161/circulationaha.106.675587 · Cited by 417
Snoep, J. D. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.15.1593 · Cited by 412
Development of aspirin resistance in persons with previous ischemic stroke.
Helgason, C. M., Bolin, K. M., Hoff, J. A., Winkler, S. R., Mangat, A., Tortorice, K. L., & Brace, L. D. (1994) · Stroke · doi:10.1161/01.str.25.12.2331 · Cited by 408
Rocca, B., Secchiero, P., Ciabattoni, G., Ranelletti, F. O., Catani, L., Guidotti, L., Melloni, E., Maggiano, N., Zauli, G., & Patrono, C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112202999 · Cited by 317
Self-citationPharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects
Capone, M. L., Sciulli, M. G., Tacconelli, S., Grana, M., Ricciotti, E., Renda, G., Di Gregorio, P., Merciaro, G., & Patrignani, P. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.045 · Cited by 279
Prevalence of persistent platelet reactivity despite use of aspirin: A systematic review
Hovens, M. M. C., Snoep, J. D., Eikenboom, J. C. J., van der Bom, J. G., Mertens, B. J. A., & Huisman, M. V. (2007) · American Heart Journal · doi:10.1016/j.ahj.2006.10.040 · Cited by 269
Reticulated platelets and uninhibited COX‐1 and COX‐2 decrease the antiplatelet effects of aspirin
GUTHIKONDA, S., LEV, E. I., PATEL, R., DELAO, T., BERGERON, A. L., DONG, J. ‐., & KLEIMAN, N. S. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02387.x · Cited by 245
Ferraris, V. A., Ferraris, S. P., Moliterno, D. J., Camp, P. C., Walenga, J. M., Messmore, H. L., Jeske, W. P., Edwards, F. H., Royston, D., Shahian, D. M., et al. (2005) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2005.01.008 · Cited by 152
Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine
Ciabattoni, G., Maclouf, J., Catella, F., FitzGerald, G. A., & Patrono, C. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90233-5 · Cited by 139
Self-citationEvangelista, V., Manarini, S., Santo, A. D., Capone, M. L., Ricciotti, E., Francesco, L. D., Tacconelli, S., Sacchetti, A., D’Angelo, S. P., Scilimati, A., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000214553.37930.3e · Cited by 127
Drug Insight: aspirin resistance—fact or fashion?
Patrono, C., & Rocca, B. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0728 · Cited by 124
Self-citationDeterminants of the interindividual variability in response to antiplatelet drugs
Rocca, B., & Patrono, C. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01380.x · Cited by 89
Self-citationAspirin Dose in Stroke Prevention: Beautiful Hypotheses Slain by Ugly Facts
Barnett, H. J. M., Kaste, M., Meldrum, H. E., & Eliasziw, M. (1996) · Stroke · doi:10.1161/01.str.27.4.588 · Cited by 69
Weber, A., Przytulski, B., Schumacher, M., Zimmermann, N., Gams, E., Hohlfeld, T., & Schrör, K. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03423.x · Cited by 55
Should Aspirin Be Discontinued Before Coronary Artery Bypass Surgery?
Sun, J. C. J., Crowther, M. A., Warkentin, T. E., Lamy, A. L., & Teoh, K. (2005) · Circulation · doi:10.1161/circulationaha.105.546697 · Cited by 21
Cited by
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Ferriero, D. M., Fullerton, H. J., Bernard, T. J., Billinghurst, L., Daniels, S. R., DeBaun, M. R., deVeber, G., Ichord, R. N., Jordan, L. C., Massicotte, P., et al. (2019) · Stroke · doi:10.1161/str.0000000000000183 · Cited by 797
Comprehensive review of cardiovascular toxicity of drugs and related agents
Mladěnka, P., Applová, L., Patočka, J., Costa, V. M., Remiao, F., Pourová, J., Mladěnka, A., Karlíčková, J., Jahodář, L., Vopršalová, M., et al. (2018) · Medicinal Research Reviews · doi:10.1002/med.21476 · Cited by 310
Platelet activation in obesity and metabolic syndrome
Santilli, F., Vazzana, N., Liani, R., Guagnano, M. T., & Davì, G. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00930.x · Cited by 258
Self-citationROCCA, B., SANTILLI, F., PITOCCO, D., MUCCI, L., PETRUCCI, G., VITACOLONNA, E., LATTANZIO, S., MATTOSCIO, D., ZACCARDI, F., LIANI, R., et al. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04723.x · Cited by 256
Self-citation
Metadata
- Authors
- Santilli, F., Rocca, B., De Cristofaro, R., Lattanzio, S., Pietrangelo, L., Habib, A., Pettinella, C., Recchiuti, A., Ferrante, E., Ciabattoni, G., Davì, G., & Patrono, C.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 53
- Issue
- 8
- Pages
- 667-677
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2112357684
- Cited by
- 265
- References
- 30
- FWCI
- 19.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.